Press "Enter" to skip to content

A PhII flop triggers an ugly rout for micro-cap biotech Aridis; Genfit CEO passes baton to successor – Endpoints News

admin 0

A PhII flop triggers an ugly rout for micro-cap biotech Aridis; Genfit CEO passes baton to successor  Endpoints News

Micro-cap biotech Aridis Pharmaceuticals $ ARDS got hammered this morning as investigators revealed that one of its clinical-stage drugs failed a mid-stage …

“liver cancer” – Google News

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *